phosphoserine has been researched along with Glioma in 3 studies
Phosphoserine: The phosphoric acid ester of serine.
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, J | 1 |
| Tien, AC | 1 |
| Alberta, JA | 1 |
| Ficarro, SB | 1 |
| Griveau, A | 1 |
| Sun, Y | 1 |
| Deshpande, JS | 1 |
| Card, JD | 1 |
| Morgan-Smith, M | 1 |
| Michowski, W | 1 |
| Hashizume, R | 1 |
| James, CD | 1 |
| Ligon, KL | 1 |
| Snider, WD | 1 |
| Sicinski, P | 1 |
| Marto, JA | 1 |
| Rowitch, DH | 1 |
| Stiles, CD | 1 |
| Means, JC | 1 |
| Gerdes, BC | 1 |
| Koulen, P | 1 |
| Golding, SE | 1 |
| Rosenberg, E | 1 |
| Valerie, N | 1 |
| Hussaini, I | 1 |
| Frigerio, M | 1 |
| Cockcroft, XF | 1 |
| Chong, WY | 1 |
| Hummersone, M | 1 |
| Rigoreau, L | 1 |
| Menear, KA | 1 |
| O'Connor, MJ | 1 |
| Povirk, LF | 1 |
| van Meter, T | 1 |
| Valerie, K | 1 |
3 other studies available for phosphoserine and Glioma
| Article | Year |
|---|---|
A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2.
Topics: Animals; Carcinogenesis; Casein Kinase II; Cell Line, Tumor; Cyclin-Dependent Kinases; Disease Model | 2017 |
Distinct Mechanisms Underlying Resveratrol-Mediated Protection from Types of Cellular Stress in C6 Glioma Cells.
Topics: Animals; Apoptosis; Caspases; Cell Line, Tumor; Cytoprotection; DNA Damage; Enzyme Activation; Gliom | 2017 |
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Movement; C | 2009 |